Dear colleagues,

On behalf of the European Association for the Study of the Liver (EASL), it gives us great pleasure to invite you to Digital NAFLD Summit 2021. The meeting will be held 16–17 September 2021.

Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease, not only in Western countries, but also across many other developed and developing countries.

In addition to state-of-the-art updates on disease definition, epidemiology, and pathophysiology from international research leaders, Digital NAFLD Summit 2021 will enable us to address many of the key challenges in clinical practice and drug development. These challenges include: identifying biomarkers for patient risk stratification, identifying disease subsets with distinct features, and developing therapeutic targets for testing in early and late phase clinical trials.

At EASL, we are committed to helping clinicians, researchers, and students to network with many and varied stakeholders in the field of hepatology. We strive to give them the opportunity to share their research and to learn among peers, across Europe and beyond.

Quentin M Anstee
Hannele Yki-Järvinen
Luca VC Valenti